Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows
Pseudomonas aeruginosa, the most common bacteria found in cystic fibrosis (CF) patients, uses a virus to go unnoticed by the host immune...
Developing a first-in-class regenerative gene therapy for cystic fibrosis
OmniSpirant Limited is an Irish company developing a regenerative gene therapy with the potential to transform respiratory medicine. The...
Symdeko Approved in Australia for CF Patients Age 12 or Older With Certain Gene Mutations
Cystic fibrosis (CF) patients in Australia age 12 and older, who have two copies of the F508del mutation in the CFTR gene (a copy...
Amphotericin B improves cystic fibrosis symptoms in cultured cells and pigs Antifungal drug forms io
An antifungal small molecule drug could restore some of the function lost in cystic fibrosis. Cystic fibrosis is a disease caused by...
Lung Enzyme Cathepsin S is New Therapeutic Target for CF and COPD
Blocking the enzyme cathepsin S can alleviate symptoms and reduce lung damage in cystic fibrosis (CF) and chronic obstructive pulmonary...
